SCHEMBL21844902

SCHEMBL21844902

C/C(=N\Nc1nc2cc(F)c(F)cc2n1C)c1ncc(F)cn1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO1 P00395 2/20 0.79
MT-CO2 P00403 2/20 0.79
EDNRA P25101 1/20 0.74
OPRM1 P35372 1/20 0.74
HTR2B P41595 1/20 0.74
KCNH2 Q12809 1/20 0.74
HTT P42858 2/20 0.40
ALOX15 P16050 1/20 0.40
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
POLB P06746 2/20 0.35
ALOX12 P18054 1/20 0.35
CYP11B2 P19099 2/20 0.35
CYP11B1 P15538 1/20 0.35
RAB9A P51151 4/20 0.34
HSP90AA1 P07900 2/20 0.34
ACACB O00763 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19449242 0.88 MT-CO1 (1.00) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449219 0.85 MT-CO1 (1.00) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449240 0.82 MT-CO1 (0.84) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449235 0.80 MT-CO1 (0.85) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449244 0.78 MT-CO1 (0.76) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449277 0.77 MT-CO1 (0.75) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449245 0.77 MT-CO1 (0.69) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449278 0.73 MT-CO1 (0.80) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449212 0.72 MT-CO1 (0.64) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449213 0.72 MT-CO1 (0.59) MT-CO1MT-CO2EDNRAOPRM1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11253517-B2 Small molecule regulators of steroid receptor coactivators and methods of use thereof BAYLOR COLLEGE OF MEDICINE (US) 2022-02-22 US disclosed
US-20200085824-A1 SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF BAYLOR COLLEGE OF MEDICINE (US) 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11253517-B2 Small molecule regulators of steroid receptor coactivators and methods of use thereof NCOA2, NCOA3, NCOA1 MT-CO1 2559/4885MT-CO2 3459/4885EDNRA 2703/4885
US-20200085824-A1 SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF NCOA2, NCOA3, NCOA1 MT-CO1 2559/4885MT-CO2 3459/4885EDNRA 2703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.